Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

UMOD genetic variations and myeloma cast nephropathy.

Belliere J, Faguer S, Huart A, Ribes D, Chassaing N, Roussel M, Chauveau D.

Clin Kidney J. 2019 Jun 15;12(5):639-640. doi: 10.1093/ckj/sfz071. eCollection 2019 Oct. No abstract available.

2.

Prognostic and Long-term Survival of Immune Thrombotic Thrombocytopenic Purpura in older patients.

Prevel R, Roubaud-Roubaud C, Gourlain S, Jamme M, Peres K, Benhamou Y, Galicier L, Azoulay E, Poullin P, Provôt F, Maury E, Presne C, Hamidou M, Saheb S, Wynckel A, Servais A, Girault S, Delmas Y, Chatelet V, Augusto JF Sr, Mousson C, Perez P, Halimi JM, Kanouni T, Lautrette A, Charvet Rumpler A, Deligny C, Chauveau D, Veyradier A Pr, Coppo P.

Blood. 2019 Sep 17. pii: blood.2019000748. doi: 10.1182/blood.2019000748. [Epub ahead of print]

PMID:
31530564
3.

The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.

Trossaert M, Graveleau J, Thiercelin-Legrand MF, Sigaud M, Guerrero F, Neel A, Fouassier M, Sailler L, Chauveau D, Ternisien C, Huart A, Gillet B, Hamidou M, Bene MC, Voisin S.

Haemophilia. 2019 May;25(3):527-534. doi: 10.1111/hae.13752. Epub 2019 May 2.

PMID:
31050100
4.

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients.

Colliou E, Karras A, Boffa JJ, Ribes D, Garrouste C, Quintrec ML, Daugas E, Huart A, Ducloux D, Hummel A, Ferrandiz I, Demoulin N, Jourde-Chiche N, Chauveau D, Audard V, Faguer S.

J Clin Med. 2019 Mar 2;8(3). pii: E298. doi: 10.3390/jcm8030298.

5.

Not only disease activity but also chronic hypertension and overweight are determinants of pregnancy outcomes in patients with systemic lupus erythematosus.

Normand G, Sens F, Puthet J, Jourde-Chiche N, Lemoine S, Chauveau D, Moranne O, Rémy P, Doret M, Daugas E, Juillard L; French Collaborative Group on Lupus Nephritis.

Lupus. 2019 Apr;28(4):529-537. doi: 10.1177/0961203319832097. Epub 2019 Feb 24.

PMID:
30799679
6.

The Effectiveness of Topical Cerium Nitrate-Silver Sulfadiazine Application on Overall Outcome in Patients with Calciphylaxis.

Darres A, Delaval R, Fournier A, Tournier E, Cointault O, Moussion F, Chauveau D, Seigneuric B, Lumbroso C, Kamar N, Ribes D, Leou S, Huart A, Testevuide P, Faguer S.

Dermatology. 2019;235(2):120-129. doi: 10.1159/000493975. Epub 2019 Jan 3.

PMID:
30605905
7.

Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.

Gribouval O, Boyer O, Hummel A, Dantal J, Martinez F, Sberro-Soussan R, Etienne I, Chauveau D, Delahousse M, Lionet A, Allard J, Pouteil Noble C, Tête MJ, Heidet L, Antignac C, Servais A.

Kidney Int. 2018 Nov;94(5):1013-1022. doi: 10.1016/j.kint.2018.07.024.

PMID:
30348286
8.

Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis.

Mourguet M, Chauveau D, Faguer S, Ruidavets JB, Béjot Y, Ribes D, Huart A, Alric L, Balardy L, Astudillo L, Adoue D, Sailler L, Pugnet G.

J Autoimmun. 2019 Jan;96:134-141. doi: 10.1016/j.jaut.2018.09.004. Epub 2018 Sep 17.

PMID:
30236485
9.

Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.

Jestin M, Benhamou Y, Schelpe AS, Roose E, Provôt F, Galicier L, Hié M, Presne C, Poullin P, Wynckel A, Saheb S, Deligny C, Servais A, Girault S, Delmas Y, Kanouni T, Lautrette A, Chauveau D, Mousson C, Perez P, Halimi JM, Charvet-Rumpler A, Hamidou M, Cathébras P, Vanhoorelbeke K, Veyradier A, Coppo P; French Thrombotic Microangiopathies Reference Center.

Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.

PMID:
30201758
10.

Winter-dormant shoot apical meristem in poplar trees shows environmental epigenetic memory.

Le Gac AL, Lafon-Placette C, Chauveau D, Segura V, Delaunay A, Fichot R, Marron N, Le Jan I, Berthelot A, Bodineau G, Bastien JC, Brignolas F, Maury S.

J Exp Bot. 2018 Sep 14;69(20):4821-4837. doi: 10.1093/jxb/ery271.

11.

Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.

Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G.

J Rheumatol. 2018 Nov;45(11):1541-1548. doi: 10.3899/jrheum.180310. Epub 2018 Jul 15.

PMID:
30008461
12.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
13.

Changes in the epigenome and transcriptome of the poplar shoot apical meristem in response to water availability affect preferentially hormone pathways.

Lafon-Placette C, Le Gac AL, Chauveau D, Segura V, Delaunay A, Lesage-Descauses MC, Hummel I, Cohen D, Jesson B, Le Thiec D, Bogeat-Triboulot MB, Brignolas F, Maury S.

J Exp Bot. 2018 Jan 23;69(3):537-551. doi: 10.1093/jxb/erx409.

PMID:
29211860
14.

Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance.

Ribes D, Hachem HEL, Oberic L, Vergez F, Delas A, Belliere J, Protin C, Kamar N, Ferrandiz I, Tavitian S, Laurent C, Huart A, Chauveau D, Ysebaert L, Faguer S.

Am J Hematol. 2018 Mar;93(3):356-362. doi: 10.1002/ajh.24984. Epub 2017 Dec 6.

15.

Clinical and genetic heterogeneity in familial steroid-sensitive nephrotic syndrome.

Dorval G, Gribouval O, Martinez-Barquero V, Machuca E, Tête MJ, Baudouin V, Benoit S, Chabchoub I, Champion G, Chauveau D, Chehade H, Chouchane C, Cloarec S, Cochat P, Dahan K, Dantal J, Delmas Y, Deschênes G, Dolhem P, Durand D, Ekinci Z, El Karoui K, Fischbach M, Grunfeld JP, Guigonis V, Hachicha M, Hogan J, Hourmant M, Hummel A, Kamar N, Krummel T, Lacombe D, Llanas B, Mesnard L, Mohsin N, Niaudet P, Nivet H, Parvex P, Pietrement C, de Pontual L, Noble CP, Ribes D, Ronco P, Rondeau E, Sallee M, Tsimaratos M, Ulinski T, Salomon R, Antignac C, Boyer O.

Pediatr Nephrol. 2018 Mar;33(3):473-483. doi: 10.1007/s00467-017-3819-9. Epub 2017 Oct 23.

PMID:
29058154
16.

Incidence and outcome of lupus nephritis in French Polynesia
.

Delarche A, Lumbroso C, Fournier A, Delaval R, Pourrat J, Testevuide P, Leou S, Cordonnier C, Chauveau D, Faguer S.

Clin Nephrol. 2018 Jan;89 (2018)(1):41-49. doi: 10.5414/CN109194.

PMID:
28933339
17.

Hepatocyte Nuclear Factor-1β Controls Mitochondrial Respiration in Renal Tubular Cells.

Casemayou A, Fournel A, Bagattin A, Schanstra J, Belliere J, Decramer S, Marsal D, Gillet M, Chassaing N, Huart A, Pontoglio M, Knauf C, Bascands JL, Chauveau D, Faguer S.

J Am Soc Nephrol. 2017 Nov;28(11):3205-3217. doi: 10.1681/ASN.2016050508. Epub 2017 Jul 24.

18.

Alternative complement pathway hemolytic assays reveal incomplete complement blockade in patients treated with eculizumab.

Puissant-Lubrano B, Puissochet S, Congy-Jolivet N, Chauveau D, Decramer S, Garnier A, Huart A, Kamar N, Ribes D, Blancher A.

Clin Immunol. 2017 Oct;183:1-7. doi: 10.1016/j.clim.2017.06.007. Epub 2017 Jun 21.

PMID:
28647502
19.

Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis.

Cariou E, Bennani Smires Y, Victor G, Robin G, Ribes D, Pascal P, Petermann A, Fournier P, Faguer S, Roncalli J, Rousseau H, Chauveau D, Carrié D, Berry I, Galinier M, Lairez O; Toulouse Amyloidosis Research Network collaborators * .

Amyloid. 2017 Jun;24(2):101-109. doi: 10.1080/13506129.2017.1333956. Epub 2017 May 29.

PMID:
28553897
20.

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome.

Jamme M, Raimbourg Q, Chauveau D, Seguin A, Presne C, Perez P, Gobert P, Wynckel A, Provôt F, Delmas Y, Mousson C, Servais A, Vrigneaud L, Veyradier A, Rondeau E, Coppo P; French Thrombotic Microangiopathies Reference Centre.

PLoS One. 2017 May 18;12(5):e0177894. doi: 10.1371/journal.pone.0177894. eCollection 2017.

21.

Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.

Grall M, Azoulay E, Galicier L, Provôt F, Wynckel A, Poullin P, Grange S, Halimi JM, Lautrette A, Delmas Y, Presne C, Hamidou M, Girault S, Pène F, Perez P, Kanouni T, Seguin A, Mousson C, Chauveau D, Ojeda-Uribe M, Barbay V, Veyradier A, Coppo P, Benhamou Y.

Am J Hematol. 2017 Apr;92(4):381-387. doi: 10.1002/ajh.24665. Epub 2017 Feb 21.

22.

The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.

Vignon M, Cohen C, Faguer S, Noel LH, Guilbeau C, Rabant M, Higgins S, Hummel A, Hertig A, Francois H, Lequintrec M, Vilaine E, Knebelmann B, Pourrat J, Chauveau D, Goujon JM, Javaugue V, Touchard G, El Karoui K, Bridoux F.

Kidney Int. 2017 Mar;91(3):720-728. doi: 10.1016/j.kint.2016.10.026. Epub 2017 Jan 6.

PMID:
28069266
23.

Asymptomatic circulating T-cell clone cause renal polymorphic inflammatory fibrosis.

Ribes D, Casemayou A, El Hachem H, Laurent C, Guilbeau-Frugier C, Vergez F, Tavitian S, Schanstra JP, Chauveau D, Bascands JL, Ysebaert L, Faguer S.

Clin Exp Nephrol. 2017 Oct;21(5):781-786. doi: 10.1007/s10157-016-1373-6. Epub 2016 Dec 26.

PMID:
28018996
24.

[French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m2)].

Jourde-Chiche N, Guerrot D, Chauveau D, Boffa JJ.

Nephrol Ther. 2017 May;13(3):138-145. doi: 10.1016/j.nephro.2016.05.011. Epub 2016 Dec 21. French. No abstract available.

PMID:
28010941
25.

Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.

Bennani Smires Y, Victor G, Ribes D, Berry M, Cognet T, Méjean S, Huart A, Roussel M, Petermann A, Roncalli J, Carrié D, Rousseau H, Berry I, Chauveau D, Galinier M, Lairez O.

Int J Cardiovasc Imaging. 2016 Sep;32(9):1403-1413. Epub 2016 May 30.

PMID:
27240600
26.

Improvement of Microstomia in Scleroderma after Carbon Dioxide Laser Treatment.

Bennani I, Lopez R, Bonnet D, Prevot G, Constantin A, Chauveau D, Paul C, Bulai Livideanu C.

Case Rep Dermatol. 2016 May 24;8(2):142-50. doi: 10.1159/000445821. eCollection 2016 May-Aug.

27.

Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units.

Guinault D, Canet E, Huart A, Jaccard A, Ribes D, Lavayssiere L, Venot M, Cointault O, Roussel M, Nogier MB, Pichereau C, Lemiale V, Arnulf B, Attal M, Chauveau D, Azoulay E, Faguer S.

Br J Haematol. 2016 Sep;174(6):868-75. doi: 10.1111/bjh.14135. Epub 2016 Jun 12.

PMID:
27292694
28.

Outcomes of patients with Goodpasture syndrome: A nationwide cohort-based study from the French Society of Hemapheresis.

Huart A, Josse AG, Chauveau D, Korach JM, Heshmati F, Bauvin E, Cointault O, Kamar N, Ribes D, Pourrat J, Faguer S; French Society of Hemapheresis.

J Autoimmun. 2016 Sep;73:24-9. doi: 10.1016/j.jaut.2016.05.015. Epub 2016 Jun 4.

PMID:
27267459
29.

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide.

Audemard-Verger A, Martin Silva N, Verstuyft C, Costedoat-Chalumeau N, Hummel A, Le Guern V, Sacré K, Meyer O, Daugas E, Goujard C, Sultan A, Lobbedez T, Galicier L, Pourrat J, Le Hello C, Godin M, Morello R, Lambert M, Hachulla E, Vanhille P, Queffeulou G, Potier J, Dion JJ, Bataille P, Chauveau D, Moulis G, Farge-Bancel D, Duhaut P, Saint-Marcoux B, Deroux A, Manuzak J, Francès C, Aumaitre O, Bezanahary H, Becquemont L, Bienvenu B.

PLoS One. 2016 Mar 22;11(3):e0151696. doi: 10.1371/journal.pone.0151696. eCollection 2016.

30.

The spectrum of renal involvement in male patients with infertility related to excretory-system abnormalities: phenotypes, genotypes, and genetic counseling.

Mieusset R, Fauquet I, Chauveau D, Monteil L, Chassaing N, Daudin M, Huart A, Isus F, Prouheze C, Calvas P, Bieth E, Bujan L, Faguer S.

J Nephrol. 2017 Apr;30(2):211-218. doi: 10.1007/s40620-016-0286-5. Epub 2016 Mar 5.

PMID:
26946416
31.

Laparoscopic nephrectomy for polycystic kidney: comparison of the transperitoneal and retroperitoneal approaches.

Benoit T, Peyronnet B, Roumiguié M, Verhoest G, Beauval JB, Delreux A, Chauveau D, Malavaud B, Manunta A, Soulié M, Rischmann P, Bensalah K, Gamé X.

World J Urol. 2016 Jul;34(7):901-6. doi: 10.1007/s00345-015-1739-5. Epub 2015 Dec 10.

PMID:
26658752
32.

Calcineurin Inhibitors Downregulate HNF-1β and May Affect the Outcome of HNF1B Patients After Renal Transplantation.

Faguer S, Esposito L, Casemayou A, Pirson Y, Decramer S, Cartery C, Hazzan M, Garrigue V, Roussey G, Cointault O, Ho T, Merville P, Devuyst O, Gourdy P, Chassaing N, Bascands JL, Kamar N, Schanstra JP, Rostaing L, Chauveau D.

Transplantation. 2016 Sep;100(9):1970-8. doi: 10.1097/TP.0000000000000993.

33.

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura.

Roriz M, Landais M, Desprez J, Barbet C, Azoulay E, Galicier L, Wynckel A, Baudel JL, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Delmas Y, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Chauveau D, Veyradier A, Halimi JM, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Medicine (Baltimore). 2015 Oct;94(42):e1598. doi: 10.1097/MD.0000000000001598.

34.

Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging.

Belliere J, Martinez de Lizarrondo S, Choudhury RP, Quenault A, Le Béhot A, Delage C, Chauveau D, Schanstra JP, Bascands JL, Vivien D, Gauberti M.

Theranostics. 2015 Aug 8;5(11):1187-202. doi: 10.7150/thno.11835. eCollection 2015.

35.

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.

de Luna G, Chauveau D, Aniort J, Carron PL, Gobert P, Karras A, Marchand-Adam S, Maurier F, Hatron PY, Mania A, le Guenno G, Bally S, Bienvenu B, Cardineau E, Goulenok T, Jourde-Chiche N, Samson M, Huart A, Pourrat J, Tiple A, Aumaitre O, Puéchal X, Heshmati F, le Jeunne C, Mouthon L, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG).

J Autoimmun. 2015 Dec;65:49-55. doi: 10.1016/j.jaut.2015.08.003. Epub 2015 Aug 29.

PMID:
26330347
36.

The authors reply.

Faguer S, Chauveau D, Decramer S, Chassaing N.

Kidney Int. 2015 Jun;87(6):1259. doi: 10.1038/ki.2015.48. No abstract available.

37.

Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience.

Terrier B, Dechartres A, Girard C, Jouneau S, Kahn JE, Dhote R, Lazaro E, Cabane J, Papo T, Schleinitz N, Cohen P, Begon E, Belenotti P, Chauveau D, Diot E, Généreau T, Hamidou M, Hayem G, Le Guenno G, Le Guern V, Michel M, Moulis G, Puéchal X, Rivière S, Samson M, Gonin F, Le Jeunne C, Corlieu P, Mouthon L, Guillevin L; French Vasculitis Study Group.

Rheumatology (Oxford). 2015 Oct;54(10):1852-7. doi: 10.1093/rheumatology/kev129. Epub 2015 May 21.

PMID:
26001634
38.

Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1.

Mansour-Hendili L, Blanchard A, Le Pottier N, Roncelin I, Lourdel S, Treard C, González W, Vergara-Jaque A, Morin G, Colin E, Holder-Espinasse M, Bacchetta J, Baudouin V, Benoit S, Bérard E, Bourdat-Michel G, Bouchireb K, Burtey S, Cailliez M, Cardon G, Cartery C, Champion G, Chauveau D, Cochat P, Dahan K, De la Faille R, Debray FG, Dehoux L, Deschenes G, Desport E, Devuyst O, Dieguez S, Emma F, Fischbach M, Fouque D, Fourcade J, François H, Gilbert-Dussardier B, Hannedouche T, Houillier P, Izzedine H, Janner M, Karras A, Knebelmann B, Lavocat MP, Lemoine S, Leroy V, Loirat C, Macher MA, Martin-Coignard D, Morin D, Niaudet P, Nivet H, Nobili F, Novo R, Faivre L, Rigothier C, Roussey-Kesler G, Salomon R, Schleich A, Sellier-Leclerc AL, Soulami K, Tiple A, Ulinski T, Vanhille P, Van Regemorter N, Jeunemaître X, Vargas-Poussou R.

Hum Mutat. 2015 Aug;36(8):743-52. doi: 10.1002/humu.22804. Epub 2015 Jun 11. Review.

PMID:
25907713
39.

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference center.

Benhamou Y, Baudel JL, Wynckel A, Galicier L, Azoulay E, Provôt F, Pène F, Mira JP, Presne C, Poullin P, Halimi JM, Rivière E, Kanouni T, Seguin A, Mousson C, Servais A, Bordessoule D, Perez P, Hamidou M, Chauveau D, Veyradier A, Coppo P.

Am J Hematol. 2015 Jun;90(6):E127-9. doi: 10.1002/ajh.23997. No abstract available.

40.

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O; Kidney Disease: Improving Global Outcomes.

Kidney Int. 2015 Oct;88(4):676-83. doi: 10.1038/ki.2015.28. Epub 2015 Mar 4.

PMID:
25738250
41.

[Autosomal dominant polycystic kidney disease].

Chauveau D, Ferrandiz I, Huart A.

Rev Prat. 2014 Nov;64(9):1313-21. Review. French. No abstract available.

PMID:
25638878
42.

Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.

Benusiglio PR, Giraud S, Deveaux S, Méjean A, Correas JM, Joly D, Timsit MO, Ferlicot S, Verkarre V, Abadie C, Chauveau D, Leroux D, Avril MF, Cordier JF, Richard S; French National Cancer Institute Inherited Predisposition to Kidney Cancer Network.

Orphanet J Rare Dis. 2014 Oct 29;9:163. doi: 10.1186/s13023-014-0163-z.

43.

Specific macrophage subtypes influence the progression of rhabdomyolysis-induced kidney injury.

Belliere J, Casemayou A, Ducasse L, Zakaroff-Girard A, Martins F, Iacovoni JS, Guilbeau-Frugier C, Buffin-Meyer B, Pipy B, Chauveau D, Schanstra JP, Bascands JL.

J Am Soc Nephrol. 2015 Jun;26(6):1363-77. doi: 10.1681/ASN.2014040320. Epub 2014 Sep 30.

44.

Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas.

Perry M, Delarche A, Ribes D, Vergez F, Guilbeau-Frugier C, Laurent C, Huart A, Tavitian S, El Hachem H, Oberic L, Chauveau D, Michallet AS, Ysebaert L, Faguer S.

Am J Hematol. 2014 Oct;89(10):969-73. doi: 10.1002/ajh.23798. Epub 2014 Jul 30.

45.

Rituximab in pure red-cell aplasia secondary to anti-erythropoietin antibodies.

Comont T, Bournet B, Casadevall N, Chauveau D, Faguer S.

Kidney Int. 2014 Jul;86(1):210-1. doi: 10.1038/ki.2014.144. No abstract available.

46.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Guitard J, Hebral AL, Fakhouri F, Joly D, Daugas E, Rivalan J, Guigonis V, Ducret F, Presne C, Pirson Y, Hourmant M, Glachant JC, Vendrely B, Moranne O, Faguer S, Chauveau D.

Nephrol Dial Transplant. 2014 Nov;29(11):2084-91. doi: 10.1093/ndt/gfu209. Epub 2014 Jun 11.

PMID:
24920841
47.

The HNF1B score is a simple tool to select patients for HNF1B gene analysis.

Faguer S, Chassaing N, Bandin F, Prouheze C, Garnier A, Casemayou A, Huart A, Schanstra JP, Calvas P, Decramer S, Chauveau D.

Kidney Int. 2014 Nov;86(5):1007-15. doi: 10.1038/ki.2014.202. Epub 2014 Jun 4. Review.

48.

[Renal unilateral oncocytis: case report].

Gryn A, Roumiguié M, Mazerolles C, Bellec L, Lagarde S, Chauveau D, Soulié M, Beauval JB.

Prog Urol. 2014 Feb;24(2):138-41. doi: 10.1016/j.purol.2013.05.011. Epub 2013 Jul 9. French.

PMID:
24485085
49.

[HNF1B-related disease: paradigm of a developmental gene and unexpected recognition of a new renal disease].

Chauveau D, Faguer S, Bandin F, Guigonis V, Chassaing N, Decramer S.

Nephrol Ther. 2013 Nov;9(6):393-7. doi: 10.1016/j.nephro.2013.05.004. Epub 2013 Oct 9. French.

PMID:
24119877
50.

Eculizumab and drug-induced haemolytic-uraemic syndrome.

Faguer S, Huart A, Frémeaux-Bacchi V, Ribes D, Chauveau D.

Clin Kidney J. 2013 Oct;6(5):484-5. doi: 10.1093/ckj/sft078. Epub 2013 Sep 5.

Supplemental Content

Loading ...
Support Center